Surrey Hospitals Foundation: COVID-19 clinical research team, study on a virtual rehabilitation clinic

THE Surrey Hospitals Foundation is supporting COVID-19 medical research in Surrey with an investment of $150,000, and has received a $150,000 matching grant from the Michael Smith Foundation for Health Research (MSFHR). The combined funds will go towards enhancing COVID-19 research initiatives and capacity to advance innovative life-saving protocols and interventions in Surrey.

The funding enables the hiring of an essential research team including a Clinical Research Coordinator, Clinical Research Nurse, and a Clinical Research Assistant at Surrey Memorial Hospital, headed by Clinical Research Lead Christopher Condin, under the guidance of Kate Keetch, Director of Evaluation and Research Services at Fraser Health.

With original seed funding of $25,000 from TELUS Friendly Future Foundation, the Surrey Hospitals Foundation is also helping fund a COVID-19 research study on the viability of a virtual rehabilitation clinic.

“We are facing a healthcare crisis with COVID-19 and it is absolutely critical for us to invest in COVID-19 research to improve the health outcomes of patients,” says Jane Adams, President and CEO of the Surrey Hospitals Foundation. “We are so grateful to the Michael Smith Foundation for Health Research for this timely grant and we are proud to support COVID-19 research initiatives and the establishment of this COVID clinical research team in Surrey.”

Dr. Greg Haljan is the head of Surrey Memorial Hospital’s critical care department and is also the Regional Medical Director of Research for Fraser Health. He will be leading the COVID-19 research study to examine whether a multi-disciplinary virtual recovery program providing pulmonary rehabilitation for COVID-19 survivors improves rehospitalization, patient quality of life and health outcomes.

He hopes to launch a COVID-19 virtual rehabilitation program at Surrey Memorial Hospital led by critical care physicians and experts. It has the potential to transform outcomes both during recovery from the pandemic and beyond, and to create measurable improvements in the quality of patients’ lives by extending the impact and reach of physiotherapy services and post-discharge care.

“Research has shown that 17 per cent survivors of similar critical illnesses, including SARS and influenza, etc., are re-admitted to hospital within one month of discharge, 30 per cent by three months and 40 per cent by six months, and COVID-19 numbers could be very similar,” says Dr. Greg Haljan, Head of the Department of Critical Care at Surrey Memorial Hospital and Regional Medical Director for Research for Fraser Health. “We need to prevent the onset of COVID-19 hospital re-admissions by developing a patient-centric, virtual critical care rehabilitation program led by critical care physicians and experts.”

“In the midst of this second wave of COVID-19, and given that Fraser Health has the highest number of cases, it is essential that we build up our COVID-19 research capacity so that we can contribute to vital evidence-based knowledge needed to combat the pandemic,” says Dr. Kate Keetch, Director, Department of Evaluation and Research Services at Fraser Health. “Our critical care physicians, including Dr. Haljan, are the most experienced in COVID-19 treatment and care, and helping support them to do cutting-edge, patient-centred research and knowledge translation as part of their clinical care, is why I head into work every morning.”

Previous research indicates that early mobility and rehabilitation, after being discharged from hospital, reduce mortality and acute care utilization in multiple critical illness survivor cohorts. Even 14 days of quarantine without hospitalization impacts fitness and mobility. Pulmonary rehabilitation improves the full spectrum of cardiopulmonary, cardiovascular, neuromuscular, and mental health domains, including surprisingly, depression, anxiety and cognition.